HCP, or Patient with a referral code?

BioCeuticals

Immunity theft, immunity debt

BioCeuticals Immunity Theft, Immunity Debt Header.png

Table of Contents

The recent resurgence of respiratory infections following the COVID-19 pandemic is a topic of great interest, with the prevalence of viral infections such as influenza and respiratory syncytial virus (RSV) on the rise around the globe.1 With COVID-19 still spreading rapidly in many countries,2 the collision of these viruses has been termed a ‘tripledemic’.3 The incidence of bacterial infections such as Streptococcus pneumoniae and group A Streptococcus have also been increasing.4